Old Web
English
Sign In
Acemap
>
authorDetail
>
S. Daniluk
S. Daniluk
Physical therapy
Rheumatoid arthritis
Placebo
Adverse effect
Medicine
3
Papers
7
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
SAT0147 Safety and Efficacy of BI 655064, An Antagonistic Anti-CD40 Antibody in Rheumatoid Arthritis (RA) Patients
2016
Annals of the Rheumatic Diseases
S. Daniluk
R. Ptaszynski
U. Mueller-Ladner
A. Petrikova
H. Kellner
Eva Dokoupilova
B Kwiatkowska
Rieke Alten
C. Schwabe
B. Rosenstock
T. Doan
R. Thiedmann
F. Fleischer
James Hilbert
Sudha Visvanathan
Steven John Padula
Jürgen Steffgen
Show All
Source
Cite
Save
Citations (4)
FRI0161 A Phase 1B/2A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of XMAB®5871 in Patients with Rheumatoid Arthritis
2015
Annals of the Rheumatic Diseases
M. Jaraczewska-Baumann
M. Korkosz
G. Sulyok
P. Šrámek
B Rojkovich
S. Daniluk
J. Bartalos
D.J. Zack
P. Foster
Show All
Source
Cite
Save
Citations (2)
SAT0254 Safety and Tolerability of the Anti-C5ar Humanised Monoclonal Antibody NNC0151-0000 in Patients with Rheumatoid Arthritis: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Multiple-Dose Trial
2014
Annals of the Rheumatic Diseases
S. Daniluk
B.K. Skrumsager
P. Leszczyński
Show All
Source
Cite
Save
Citations (1)
1